Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study

TK Tzatzairis, GI Drosos, SE Kotsios… - The Journal of …, 2016 - Elsevier
Background Use of tranexamic acid (TXA) is effective and safe in reducing the blood loss in
total knee arthroplasty (TKR) performed using a tourniquet, but, data in TKR performed …

Multiple intravenous tranexamic acid doses in total knee arthroplasty without tourniquet: a randomized controlled study

T Tzatzairis, GI Drosos, T Vogiatzaki, K Tilkeridis… - Archives of orthopaedic …, 2019 - Springer
Background Tranexamic acid (TXA) is widely used in the orthopedic field and particularly in
total knee arthroplasty (TKA). Its efficacy and safety in reducing the blood loss in TKA have …

[HTML][HTML] Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration

D Wang, HY Wang, C Cao, LL Li, WK Meng, FX Pei… - Scientific reports, 2018 - nature.com
Abundant literature confirms that intravenous (IV) and intra-articular (IA) administration of
tranexamic acid (TXA) reduces blood loss in total knee arthroplasty (TKA). Oral formulations …

Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis

YS Shin, JR Yoon, HN Lee, SH Park… - Knee Surgery, Sports …, 2017 - Springer
Purpose This meta-analysis was designed to compare the effectiveness and safety of
intravenous (IV) versus topical administration of tranexamic acid (TXA) in patients …

Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study

M Morales Santias, J Mas Martinez… - European Journal of …, 2020 - Springer
Purpose Tranexamic acid (TXA) has been shown to be effective in reducing blood loss after
total knee replacement. The purpose of this study was to prospectively assess the …

[HTML][HTML] Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized …

D Wang, H Zhu, WK Meng, HY Wang, ZY Luo… - BMC musculoskeletal …, 2018 - Springer
Background Although randomized controlled trials have confirmed oral tranexamic acid
(TXA) can provide similar blood-sparing efficacy compared with intravenous (IV) TXA in total …

Intravenous versus topical tranexamic acid in total knee arthroplasty: both effective in a randomized clinical trial of 640 patients

MP Abdel, BP Chalmers, MJ Taunton, MW Pagnano… - Jbjs, 2018 - journals.lww.com
Background: Tranexamic acid (TXA) reduces bleeding and the need for transfusion after
total knee arthroplasty. Most literature has focused on intravenous (IV) administration of TXA …

[HTML][HTML] Tranexamic acid reduces blood loss and transfusion in patients undergoing total knee arthroplasty without tourniquet: a prospective randomized controlled …

F Bidolegui, G Arce, A Lugones, S Pereira… - The open …, 2014 - ncbi.nlm.nih.gov
Methods: We performed a prospective randomized controlled trial (1: 1 fashion) on the use
of tranexamic acid versus placebo in 50 patients undergoing TKA (without tourniquet). The …

[HTML][HTML] The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of …

H Xiong, Y Liu, Y Zeng, Y Wu, B Shen - BMC musculoskeletal disorders, 2018 - Springer
Background The combined administration of intravenous (IV) and topical tranexamic acid
(TXA) in primary total knee (TKA) knee remains controversial. The purpose of this meta …

Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: a …

G Cao, J Xie, Z Huang, Q Huang, G Chen, Y Lei… - Thrombosis research, 2018 - Elsevier
Introduction The aim of this study was to examine whether the administration of multiple
boluses of oral or intravenous tranexamic acid (TXA) postoperatively were equivalent at …